Press Releases

John M. Burke, MD is now editor-in-chief for Targeted Oncology. Burke brings his expertise in blood cancers and non-cancerous blood disorders to the role.

Targeted Oncology™ announced the launch of its new clinical trial database.

The privately-owned health care media company, is excited to officially announce that it has expanded its Strategic Alliance Partnership program with the addition of the Global Liver Institute, a collaborative and innovative platform for the entire spectrum of liver diseases and liver health advocates.

Targeted Oncology™ is excited to announce it has expanded its Strategic Alliance Partnership program with the addition of the Kentucky Society of Clinical Oncology and Virginia Cancer Specialists, strengthening its position in the oncology space.

Targeted Oncology, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, has added the Pennsylvania Society of Oncology and Hematology to its Strategic Alliance Partnership program.

Targeted Oncology, a multimedia resource that offers informative content and expert opinions on standard and emerging treatments in the field of oncology, announces the launch of its new podcast series, “Targeted Talks.”

Targeted Oncology, a multimedia resource that offers engaging content and expert opinions on standard and emerging treatments in the field of oncology, announces the addition of Tennessee Oncology to their Strategic Alliance Partnership program.

Targeted Oncology, a multimedia resource that offers content and expert opinions on standard and emerging treatments in the oncology field, announces the addition of the Society of Hematologic Oncology to its Strategic Alliance Partnership program.

<em>Targeted Oncology</em>&trade;,&nbsp;a multimedia resource that offers content and expert opinions on standard and emerging treatments in the oncology field, announces the addition of the Medical Oncology Association of Southern California (MOASC) to its Strategic Alliance Partnership program.<br /> <br /> &nbsp;

MJH Associates&sbquo; Inc. announces a Strategic Alliance Partnership between Hematology-Oncology Associates of Central New York and Targeted Oncology.

Targeted Oncology&trade;&nbsp;announces the addition of Carolina Blood and Cancer Care to their Strategic Alliance Partnership programs.<br /> &nbsp;

Targeted Oncology,&nbsp;a multimedia resource that offers content and expert opinions on standard and emerging treatments in the oncology field, announces the addition of The Florida Society of Clinical Oncology to its Strategic Alliance Partnership program.

<em>Targeted Therapies in Oncology</em>, an oncology publication that provides oncology professionals with cutting-edge research, data, and treatment strategies surrounding molecular and immune system targets, has appointed&nbsp;Robert L. Ferris, MD, PhD,&nbsp;as its co-physician editor-in-chief.

<em>Targeted Oncology</em>&trade; will launch its third &ldquo;Expert Perspective: Virtual Tumor Board&rdquo; on Monday, September 24.&nbsp;Each Virtual Tumor Board is a video-editorial discussion that features key opinion leaders from a specific oncological field considering options for treating patients based on case scenarios. This episode will focus on multiple myeloma.

<em>Targeted Oncology</em>, a print and digital resource that offers content and expert opinions on precision medicine in oncology, launched its second &ldquo;Expert Perspective: Virtual Tumor Board&rdquo; on Wednesday, September 12. The Virtual Tumor Board is a video-editorial board discussion that features key opinion leaders from a specific oncological field. This episode will focus on non&ndash;small cell lung cancer.

<em>Targeted Oncology</em>, a print and digital resource that offers content and expert opinions on precision medicine in oncology, becomes partners with the International Liver Cancer Association, announced Michael J. Hennessy Jr., president of MJH Associates Inc., parent company of <em>Targeted Oncology.</em>

<em>Targeted Oncology</em>&trade;, a print and digital resource that offers content and expert opinions on precision medicine in oncology, will launch the first Expert Perspective: Virtual Tumor Board on April 30. The Virtual Tumor Board is a video-editorial board discussion that features key opinion leaders from a specific oncological field.

<em>Targeted Therapies in Oncology</em>, an oncology resource that provides oncology professionals with cutting-edge research, data, and treatment strategies surrounding molecular and immune system targets, welcomes&nbsp;Arjun V. Balar, MD,&nbsp;as its editor-in-chief.